Evaluation of the sterility testing process of hematopoietic stem cells at Canadian Blood Services

Transfusion

Volumn 52, Issue 8, 2012, Pages 1778-1784

  Mastronardi, Cherie ^a   Yang, Lin ^a   Halpenny, Mike ^a   Toye, Baldwin ^a   Ramírez Arcos, Sandra ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AEROBIC CELL CULTURE; AGAR DIFFUSION; ANAEROBIC CELL CULTURE; APHERESIS; ARTICLE; BACILLUS CEREUS; BACTERIAL COLONIZATION; BACTERIUM CONTAMINATION; BACTERIUM IDENTIFICATION; BACTEROIDES FRAGILIS; BLOOD BANK; BLOOD SAMPLING; BONE MARROW; CANDIDA ALBICANS; COLONY FORMING UNIT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CRYOPRESERVATION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MICROBIOLOGICAL EXAMINATION; NONHUMAN; PLATING MEDIUM; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS EPIDERMIDIS; STERILITY TESTING; UMBILICAL CORD BLOOD;

BACTEREMIA; BACTERIA, AEROBIC; BACTERIA, ANAEROBIC; BLOOD BANKS; BLOOD COMPONENT REMOVAL; BLOOD PRESERVATION; BLOOD SPECIMEN COLLECTION; CANADA; CANDIDIASIS; CRYOPRESERVATION; FETAL BLOOD; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MICROBIOLOGICAL TECHNIQUES; QUALITY CONTROL; STERILIZATION;

EID: 84864966463     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2011.03530.x     Document Type: Article

References (24)

1. Klein M, Kadidlo D, McCullough J, McKenna D, Burns LJ,. Microbial contamination of hematopoietic stem cell products: incidence and clinical sequelae. Biol Blood Marrow Transplant 2006; 12: 1142-9.
2. Padley DJ, Dietz AB, Gastineau DA,. Sterility testing of hematopoetic progenitor cell products: a single-institution series of culture-positive rates and successful infusion of culture-positive products. Transfusion 2007; 47: 636-43.
3. Khuu HM, Patel N, Carter CS, Murray PR, Read EJ,. Sterility testing of cell therapy products: parallel comparison of automated methods with a CFR-compliant method. Transfusion 2006; 46: 2071-82.
4. Riedel S, Junkins A, Stamper PD, Cress G, Widness JA, Doern GV,. Comparison of Bactec 9240 and BacT/ALERT blood culture systems for evaluation of placental cord blood for transfusion in neonates. J Clin Microbiol 2009; 47: 1645-9.
5. Honohan A, Olthuis H, Bernards AT, van Beckhoven JM, Brand A,. Microbial contamination of cord blood stem cells. Vox Sang 2002; 82: 32-8.
6. Food and Drug Administration, Center for Biologics Evaluation and Research. Guidance for industry: current good tissue practice (CGTP) and additional requirements for manufacturers of human cells, tissues, and cellular and tissue-based products (HCT/Ps). 2009. 21 CFR part 1270 and 1271. [cited 2011 Sep 2]. Available from: URL: http://www.fda.gov/downloads/ BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Tissue/ UCM091408.pdf
7. American Association of Blood Banks. Standards for cellular therapy product services. 4th ed. Bethesda (MD): American Association of Blood Banks; 2009.
8. th edition. 2011. [cited 2011 Sep 2]. Available from: URL: http://www.factwebsite.org/uploadedFiles/FACT-News/ Final%20Draft%205th%20Edition%20Accreditation%20Manual.04.18.11.pdf
9. General biological products standardsâ€"sterility, 21 CFR Sect. 610.12. 2011. [cited 2011 Nov 14]. Available from: URL: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=610.12
10. McDonald CP, Roy A, Ball J, De Ritis R, Ancliff S, Baklan H, Goodhand K, Robbins S, Hartley S, Walker J, Collins A,. Screening of cord blood donations in 2010 [abstract]. Vox Sang 2011; 101 (Suppl 1): 224.
11. Sparrow RL,. Microbial screening of UC cord blood units by an automated culture system: effect of delayed testing on bacterial detection. Cytotherapy 2004; 6: 23-9.
12. Khuu HM, Stock F, McGann M, Carter CS, Atkins JW, Murray PR, Read EJ,. Comparison of automated culture systems with a CFR/USP-compliant method for sterility testing of cell-therapy products. Transfusion 2006; 46: 2071-82.
13. Â 3D system for the implementation of in-house quality control sterility testing at Canadian Blood Services. Clin Chem Lab Med 2010; 48: 1179-87.
14. Little RC, Milliken GA, Stroup WW, Wolfinger R,. SAS system for mixed models. Cary (NC): SAS institute Inc; 1996.
15. Akan OA, Yildiz E,. Comparison of the effect of delayed entry into 2 different blood culture systems (BACTEC 9240 and BacT/ALERT 3D) on culture positivity. Diagn Microbiol Infect Dis 2006; 54: 193-6.
16. bioMérieux, Inc., Important notice for BacT/ALERT users performing platelet quality control testing. bioMérieux Connection Newsletter. 2004; 1: 8-9. [cited 2011 Sep 29]. Available from: URL: http://www.biomerieux- usa.com/upload/v1n2-1.pdf
17. Sautter RL, Bills AR, Lang DL, Ruschell G, Heiter BJ, Bourbeau PP,. Effects of delayed-entry conditions on the recovery and detection of microorganisms from BacT/ALERT and BACTEC blood culture bottles. J Clin Microbiol 2006; 44: 1245-9.
18. McDonald CP, Ray A, Lowe P, Hartley S, Robbins S, Barbara AJ,. Bacteriological testing of volume reduced cord blood [abstract]. American Society for Microbiology Annual Meeting 1999.
19. Rodriguez F, Khan A,. Sterility testing for cellular therapy products. ISCT webinar, November 18, 2009. [cited 2011 Sep 13]. Available from: URL: http://www.celltherapysociety.org/index.php/meetings-events/webinars/ 2009-webinars-2
20. Wall D,. Determining and validating acceptable microbial contamination rates for PBSC processing. Peter MacCallum Cancer Centre Australia (oral presentation), 2006.
21. Panterne B,. Use of a blood culture method for the microbiological control of cellular products. AFSSAPS (oral presentation). 2006.
22. Wood T,. Validation of the BacT/ALERT as an alternative sterility test for Dendreon's autologous cell therapy product. Somatic Cell Therapy Symposium (oral presentation), September 28, 2007.
23. Jenkins C, Ramírez-Arcos S, Goldman M, Devine DV,. Bacterial contamination in platelets: incremental improvements drive down but do not eliminate risk. Transfusion 2011; 51: 2555-65.
24. Montag T, Nicol SB, Schrig U, Heiden M, Huber H, Sanzenbacher R, Flory E, Schwanig M, Schneider CK,. Microbial safety of cell based medicinal productsâ€"what can we learn from cellular blood components? Clin Chem Lab Med 2008; 46: 963-5.